Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS)
NANot yet recruitingINTERVENTIONAL
Enrollment
400
Participants
Timeline
Start Date
October 1, 2025
Primary Completion Date
January 1, 2028
Study Completion Date
April 2, 2028
Conditions
Antiphospholipid Syndrome
Interventions
OTHER
Collectio nof blood
Collection of an additional volume of blood in the initial blood test.
Trial Locations (1)
Unknown
Damien JOLLY, Reims
All Listed Sponsors
lead
CHU de Reims
OTHER
NCT07163338 - Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) | Biotech Hunter | Biotech Hunter